University Medical Center Groningen

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1614-01-01

Employees: 10K

Market Cap: -

Website: https://www.umcg.nl

Clinical Trials

Pharmacokinetic Parameters of Co-trimoxazole

Phase 2

Completed

Conditions: Tuberculosis

Interventions: Drug: co-trimoxazole

First Posted Date: 2013-04-16

Last Posted Date: 2014-09-16

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 12

Registration Number: NCT01832987

Locations: 🇳🇱
UMCG - Tuberculosis Center, Groningen, Netherlands

Clinical Value of 89Zr-trastuzumab PET

Phase 2

Completed

Conditions: Metastatic Breast Cancer

Interventions: Drug: 89Zr-trastuzumab injection

First Posted Date: 2013-04-15

Last Posted Date: 2015-11-05

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 20

Registration Number: NCT01832051

Locations: 🇳🇱
University Medical Center, Groningen, Netherlands

89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients

Phase 1

Completed

Conditions: Ovarian Neoplasms
Pancreatic Neoplasms
Digestive System Neoplasms
Ovarian Diseases
Adnexal Diseases
Digestive System Diseases
Pancreatic Diseases

Interventions: Drug: 89Zr-MMOT0530A

First Posted Date: 2013-04-15

Last Posted Date: 2024-05-03

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 11

Registration Number: NCT01832116

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇳🇱
VU Medical Center, Amsterdam, Netherlands

Non-invasive and Invasive Assessment of Coronary Artery Disease

Not Applicable

Terminated

Conditions: Coronary Artery Disease

Interventions: Device: adenosine stress Cardiac Magnetic Resonance Imaging

First Posted Date: 2013-04-04

Last Posted Date: 2018-05-04

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 120

Registration Number: NCT01823809

Locations: 🇳🇱
University Medical Center Groningen, Departments of Cardiology and Radiology, Groningen, Netherlands
🇸🇪
University Hospital Linköping, Departments of Clinical Physiology, Cardiology and Center for Medial Imaging Visualization, Linköping, Sweden

Shared Care Follow-up After Chemotherapy for Testicular Cancer

Active, not recruiting

Conditions: Testicular Cancer

First Posted Date: 2013-02-04

Last Posted Date: 2024-05-03

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 163

Registration Number: NCT01783145

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

Feasability Test of a Handset Device to Detect Levels of Sedation and Loss of Consciousness

Completed

Conditions: Conscious Sedation

First Posted Date: 2013-01-29

Last Posted Date: 2024-04-18

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 20

Registration Number: NCT01778608

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

Brain Function and Perfusion in Patients With Heart Failure

Conditions: Heart Failure
Dilated Cardiomyopathy
Perfusion
Cognitive Impairment
Cerebral Hypoperfusion

First Posted Date: 2012-12-24

Last Posted Date: 2012-12-24

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 45

Registration Number: NCT01756014

Locations: 🇳🇱
University Medical Centre Groningen, Groningen, Netherlands

Effects of QVAR in Smokers With Asthma

Phase 4

Completed

Conditions: Asthma

Interventions: Drug: Beclomethasone (QVAR)
Drug: Beclomethasone (Clenil)
Drug: Fluticasone

First Posted Date: 2012-12-04

Last Posted Date: 2016-08-26

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 40

Registration Number: NCT01741285

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

PK/PD of Ertapenem In Patients With TB

Phase 2

Completed

Conditions: PK of Ertapenem in TB Patients

Interventions: Drug: ertapenem

First Posted Date: 2012-11-21

Last Posted Date: 2017-08-25

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 12

Registration Number: NCT01730664

Locations: 🇳🇱
UMCG - Tuberculosis Center, Groningen, Netherlands

Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH

Phase 3

Completed

Conditions: Heart Failure, Diastolic
Pulmonary Hypertension

Interventions: Drug: Sildenafil
Drug: Placebo

First Posted Date: 2012-11-14

Last Posted Date: 2016-03-21

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 52

Registration Number: NCT01726049

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy